MedTrace Logo

A Survey on Blood Transfusions in Major Artrhoplasty Operations

NCT03282201 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 418

Last updated 2018-11-02

No results posted yet for this study

Summary

The rate of hip, knee arthroplasties and their revision are increasing every year. The incidence of blood transfusion in these operations are reported 18%, 68%, and 39%, 67%, respectively. Blood transfusion is known to increase the risk of pulmonary, septic, wound and thromboembolic complications and is related to mortality. Restrictive transfusion protocols has cost-effective results in terms of reducing these complications, promoting early discharge and reduced frequency of re-admission.

Within this context, we aimed to evaluate the transfusion practice in our hospital, define the transfusion indicators and compare the transfused and non transfused patients in terms of recovery.

Conditions

  • Arthropathy of Hip
  • Arthropathy of Knee

Interventions

OTHER

Transfusion

Transfusion of red blood cells, fresh frozen plasma, platelets

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • Dilek Yazicioglu, Assoc Prof · Ministry of Health

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-15
Primary Completion
2018-05-25
Completion
2018-06-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03282201 on ClinicalTrials.gov